Solasia Pharma K.K. (TSE : 4597) acquired Episil oral liquid business from Camurus AB (OM : CAMX).
Solasia Pharma K.K. (TSE : 4597) completed the acquisition of Episil oral liquid business from Camurus AB (publ) (OM : CAMX) on July 8, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27 JPY | 0.00% | 0.00% | -40.00% |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 31.53M | |
-2.35% | 89.08B | |
+2.76% | 40.9B | |
-12.92% | 32.25B | |
+54.69% | 25.14B | |
-16.51% | 15.39B | |
-8.27% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |